GFAP and demyelinating disease of central nervous system: The serum was negative for antibodies associated with CNS demyelinating diseases, such as antibodies to aquaporin 4 (AQP-4), glial acidic fibrillary protein (GFAP), and myelin oligodendrocyte glycoprotein (MOG).